Christopher J Jolly - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher J Jolly

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|August 28, 2024

TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.

Science Translational Medicine|May 17, 2023

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.

Cell|September 18, 2018

An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney FibrosisBen Roediger, Quintin Lee, Shweta Tikoo, et al.

Nature Communications|May 13, 2025

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCsJulie A I Thoms, Feng Yan, Henry R Hampton, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature Communications|August 28, 2024

TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cellsPeter Truong, Sylvie Shen, Swapna Joshi, et al.

Science Translational Medicine|May 17, 2023

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemiaErnest Moles, Christopher B Howard, Pie Huda, et al.

Cell|September 18, 2018

An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney FibrosisBen Roediger, Quintin Lee, Shweta Tikoo, et al.

Nature Communications|May 13, 2025

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCsJulie A I Thoms, Feng Yan, Henry R Hampton, et al.

Pageof 3